The Art and Science of Managing the New Melanoma Landscape
On Demand Lectures
Oct. 17, 2020 - April 16, 2021
Conf. #: E122533
5.25 AMA PRA Category 1 CreditsTM
When you register for Canvas access, please allow up to 72 hours to receive the invitation link. The invitation will come from Instructure Canvas.
- Access to an online course syllabus (with pre-recorded lectures and downloadable pdf files)
- Online course will be available until April 16, 2021
- This activity has been approved for AMA PRA Category 1 Credit™” and will also offer MOC points (ABIM). A certificate will be emailed after a post-test is passed and a course evaluation is completed.
- CME credit and MOC points (ABIM) will be offered for this course and a certificate will be available after a post-course evaluation is complete.
- You must pass a post test in order to claim CME and/or MOC points
Note: You will need to watch all of the videos before taking the post-test and course evaluation to claim credit.
Deadline to claim CME credits and/or MOC points for the on-demand course is: Friday, April 16, 2021.
The diagnosis, prognosis, and management of patients with melanoma and non-melanoma skin cancers are evolving rapidly due to new understanding, guidelines, and regulatory approvals. Due to these changes, there are many areas of need for physician education in order to optimize the care of patients with these diseases. Thus, this educational activity will reach clinicians in both the academic and community clinical settings to raise the level of knowledge about current and emerging treatment options for patients with melanoma and non-melanoma skin cancers. The activity will use a virtual format to allow increased and safe access to this valuable educational opportunity.
The University of Texas MD Anderson Cancer Center will develop a high-quality educational activity that is designed to overcome barriers to optimized patient care in the rapidly changing landscape of melanoma and non-melanoma skin cancers. To address the performance gaps, educational needs, and subsequent learning objectives, we recommend support for the development and execution of a national educational conference. MD Anderson will utilize a virtual format that includes both online recorded materials and live web-based interactive discussions to provide a safe environment for learning, engagement, and dialogue with peers and presenters. The initiative is anticipated to increase understanding and competency through expert presentations and related panel discussion on representative clinical cases.
The conference will comprise of online recorded materials organized around key clinical scenarios. These will complement the panel discussions of cases, which will be used to illustrate related concepts and controversies. Both the talks and the discussion will be led by multidisciplinary national experts in melanoma and non-melanoma skin cancers. With the focus on multidisciplinary management, the scientific agenda will be comprehensive and effective in addressing the educational needs of the target audience of clinicians and caregivers. It will also address the importance of multidisciplinary communications and management strategies for patient management along the disease continuum.
After viewing the videos, participants should be able to:
- Utilize the latest criteria and clinical evidence for treatment options for melanoma patients with clinically localized disease and interpret the components of the updated AJCC staging system for melanoma;
- Make evidence-based decisions about the use of adjuvant immune and targeted therapies in patients with surgically resected stage III disease;
- Make evidence-based decisions about the optimal selection and use of immunotherapy and targeted therapy in patients with stage IV metastatic disease;
- Understand the current data about the role of different treatment modalities, including immune and targeted therapies, in patients with brain metastases and with non-cutaneous melanomas ;
- Understand the current data about the role of immunotherapy in the management of patients with non-melanoma skin cancer, including cutaneous squamous cell carcinoma and Merkel cell carcinoma.
On-Demand Lectures: If you register and watch all of the pre-recorded videos on-line, the post-test and evaluation links will be provided to you at the conclusion of the final video.
The University of Texas MD Anderson Cancer Center is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Texas MD Anderson Cancer Center designates this internet enduring material for a maximum of 5.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM Maintenance of Certification
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 5.25 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Participant completion data will be shared with and transmitted to the ACCME on the participant’s behalf.
In order to receive MOC points, you must pass the post-test with a score of 70% or higher.
CME Certificates and Attendance Verification Certificates
Certificates awarding AMA PRA Category 1 Credit™ or certificates documenting attendance will be distributed to participants when an individual departs the conference. To obtain a CME certificate, physicians must submit a completed evaluation questionnaire and a CME verification form. Upon request, a record of attendance (certificate) will be provided to other health care professionals for requesting credits in accordance with state nursing boards, specialty societies or other professional associations.
The University of Texas MD Anderson Cancer Center has implemented a process whereby everyone who is in a position to control the content of an educational activity must disclose all relevant financial relationships with any commercial interest that could potentially affect the information presented. MD Anderson also requires that all faculty disclose any unlabeled use or investigational use (not yet approved for any purpose) of pharmaceutical and medical device products. Specific disclosure will be made to the participants prior to the educational activity.
Physician Payments Sunshine Act
MD Anderson complies with the Physician Payments Sunshine Act as part of the Affordable Care Act (ACA). Accordingly, we may be required to collect information on transfer of value to any covered recipient under the ACA.